These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2424874)
1. Recognition of distinct epitopes on the HLA-A2 antigen by cytotoxic T lymphocytes. van der Poel JJ; Pool J; Goulmy E; Giphart MJ; van Rood JJ Hum Immunol; 1986 Jul; 16(3):247-58. PubMed ID: 2424874 [TBL] [Abstract][Full Text] [Related]
2. Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. II. Definition of three HLA-A2 subtypes by CTLs. van der Poel JJ; Pool J; Goulmy E; van Rood JJ Immunogenetics; 1983; 17(6):599-608. PubMed ID: 6190741 [TBL] [Abstract][Full Text] [Related]
3. Definition of four HLA-A2 subtypes by CML typing and biochemical analysis. van der Poel JJ; Mölders H; Thompson A; Ploegh HL Immunogenetics; 1983; 17(6):609-21. PubMed ID: 6407985 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the functional epitopes on different HLA-A2 molecules. Goulmy E; van der Poel J; Giphart M; van Rood JJ Immunogenetics; 1984; 20(1):13-21. PubMed ID: 6204938 [TBL] [Abstract][Full Text] [Related]
5. Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. I. Population studies. Horai S; van der Poel JJ; Goulmy E Immunogenetics; 1982; 16(2):135-42. PubMed ID: 6183196 [TBL] [Abstract][Full Text] [Related]
6. Activation of cytotoxic T lymphocytes in HLA-A, -B and -C-identical responder-stimulator pairs. II. New subtypes of HLA-Bw35. Breuning MH; Breur BS; Engelsma MY; Goulmy E; Iványi P Tissue Antigens; 1984 Aug; 24(2):90-7. PubMed ID: 6208634 [TBL] [Abstract][Full Text] [Related]
7. Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule. Brenner MB; McLean J; Yang SY; van der Poel JJ; Pious D; Strominger JL J Immunol; 1985 Jul; 135(1):384-90. PubMed ID: 2582041 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the HLA-A2.2 subtype: T cell evidence for further heterogeneity. Gotch FM; Kelly C; Ellis SA; Wallace L; Rickinson AB; van der Poel J; Crumpton MJ; McMichael AJ Immunogenetics; 1985; 21(1):11-23. PubMed ID: 2981768 [TBL] [Abstract][Full Text] [Related]
9. Conventional alloantisera can recognize the same HLA-B27 polymorphism as detected by cytotoxic T lymphocytes. de Waal LP; Krom FE; Breur-Vriesendorp BS; Engelfriet CP; Lopez de Castro JA; Ivanyi P Hum Immunol; 1987 Dec; 20(4):265-71. PubMed ID: 2449411 [TBL] [Abstract][Full Text] [Related]
10. A cloned cytotoxic T-lymphocyte (CTL) line recognizing a subtype of HLA B27. Breuning MH; Spits H; de Vries JE; Iványi P Hum Immunol; 1984 Apr; 9(4):231-42. PubMed ID: 6201469 [TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of an HLA-A2 functional variant CLA defined by cytolytic T lymphocytes. Ezquerra A; Doménech N; van der Poel J; Strominger JL; Vega MA; López de Castro JA J Immunol; 1986 Sep; 137(5):1642-9. PubMed ID: 3489037 [TBL] [Abstract][Full Text] [Related]
12. Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line. Ware CF; Krangel MS; Pious D; Burakoff SJ; Strominger JL J Immunol; 1983 Sep; 131(3):1312-7. PubMed ID: 6193184 [TBL] [Abstract][Full Text] [Related]
13. In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA molecule. Salter RD; Clayberger C; Lomen CE; Krensky AM; Parham P J Exp Med; 1987 Jul; 166(1):283-8. PubMed ID: 2439636 [TBL] [Abstract][Full Text] [Related]
14. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients. Jaramillo A; Narayanan K; Campbell LG; Benshoff ND; Lybarger L; Hansen TH; Fleming TP; Dietz JR; Mohanakumar T Breast Cancer Res Treat; 2004 Nov; 88(1):29-41. PubMed ID: 15538043 [TBL] [Abstract][Full Text] [Related]
15. Allospecific T cell recognition of HLA-A2 antigens: evidence for group-specific and subgroup-specific epitopes. Wallace LE; Houghton MA; Rickinson AB; Epstein MA; Bradley BA Immunogenetics; 1985; 21(3):201-14. PubMed ID: 2580783 [TBL] [Abstract][Full Text] [Related]
16. Delineation of immunologically and biochemically distinct HLA-A2 antigens. Biddison WE; Kostyu DD; Strominger JL; Krangel MS J Immunol; 1982 Aug; 129(2):730-4. PubMed ID: 6177780 [TBL] [Abstract][Full Text] [Related]
17. Cytotoxic T lymphocyte-defined epitope differences between HLA-A2.1 and HLA-A2.2 map to two distinct regions of the molecule. Hogan KT; Clayberger C; Le AX; Walk SF; Ridge JP; Parham P; Krensky AM; Engelhard VH J Immunol; 1988 Dec; 141(11):4005-11. PubMed ID: 2460555 [TBL] [Abstract][Full Text] [Related]
18. Reactivity patterns with HLA-A2 variants indicate lack of identity between determinants defined by monoclonal antibodies and cytotoxic-T-cell clones. Russo C; Flomenberg N; Dupont B; Ferrone S Cell Immunol; 1984 Oct; 88(1):228-32. PubMed ID: 6206957 [TBL] [Abstract][Full Text] [Related]
19. The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificity. Bernhard EJ; Le AX; Yannelli JR; Holterman MJ; Hogan KT; Parham P; Engelhard VH J Immunol; 1987 Dec; 139(11):3614-21. PubMed ID: 2445816 [TBL] [Abstract][Full Text] [Related]
20. Fine specificity of human HLA-B7-specific cytotoxic T-lymphocyte clones. I. Identification of HLA-B7 subtypes and histotopes of the HLA-B7 cross-reacting group. van Seventer GA; Huis B; Melief CJ; Iványi P Hum Immunol; 1986 Aug; 16(4):375-89. PubMed ID: 2428783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]